MARKET

SLS

SLS

Sellas Life Sciences Group Inc
NASDAQ
8.03
-0.39
-4.63%
After Hours: 9.65 +1.62 +20.13% 19:59 11/12 EST
OPEN
8.16
PREV CLOSE
8.42
HIGH
8.41
LOW
8.00
VOLUME
4.38M
TURNOVER
--
52 WEEK HIGH
15.88
52 WEEK LOW
1.390
MARKET CAP
1.62B
P/E (TTM)
-37.1072
1D
5D
1M
3M
1Y
5Y
1D
Sellas Life Sciences shares jump as key leukemia trial results near
Seeking Alpha · 5h ago
Closing Bell Movers: Cerebras jumps 18% after Q3 earnings beat
TipRanks · 7h ago
Sellas Life Sciences reports Q3 EPS (5c) vs. (6c) last year
TipRanks · 8h ago
SELLAS Life Sciences GAAP EPS of -$0.05 in-line
Seeking Alpha · 11h ago
*SELLAS Life Sciences 3Q Loss/Shr 5c >SLS
Dow Jones · 11h ago
Press Release: SELLAS Life Sciences Reports Third -2-
Dow Jones · 11h ago
Press Release: SELLAS Life Sciences Reports Third Quarter 2026 Financial Results and Provides Corporate Update
Dow Jones · 11h ago
How Investors Are Reacting To SELLAS Life Sciences Group Stock As Final Trial Analysis Begins
Simply Wall St · 18h ago
More
About SLS
SELLAS Life Sciences Group, Inc. is a late-stage clinical biopharmaceutical company. The Company is focused on the development of therapeutics for a range of cancer indications. The Company's product candidates are galinpepimut-S (GPS), a peptide immunotherapy directed against the Wilms tumor 1 (WT1), antigen, and SLS009, a selective small molecule cyclin-dependent kinase 9 (CDK9) inhibitor. GPS is a cancer immunotherapeutic agent licensed by Memorial Sloan Kettering Cancer Center (MSK), that targets the WT1 protein, which is present in an array of tumor types. GPS has potential as a monotherapy or in combination with other immunotherapeutic agents to address a broad spectrum of hematologic malignancies and solid tumor indications. The Company is developing SLS009, which is licensed by GenFleet Therapeutics (Shanghai), Inc., for all therapeutic and diagnostic uses in the world outside of mainland China, Hong Kong, Macau, and Taiwan.

Webull offers Sellas Life Sciences Group Inc stock information, including NASDAQ: SLS real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SLS stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SLS stock methods without spending real money on the virtual paper trading platform.